Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Laurent M. Willems, Johann Philipp Zöllner, Esther Paule, Susanne Schubert-Bast, Felix Rosenow & Adam Strzelczyk. (2018) Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence. Expert Review of Clinical Pharmacology 11:3, pages 309-324.
Read now
Read now
Monika Banach, Kinga K Borowicz & Stanisław J Czuczwar. (2015) Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 639-648.
Read now
Read now
Articles from other publishers (19)
Muhammad Ikram & Sufian Rasheed. (2023) Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine:
A Roadmap for Future Treatment of Drug Resistant Seizures. Current Molecular Pharmacology 16:4, pages 475-493.
Crossref
Crossref
Harikumar Rajaguru & R. Karthikamani. (2022) Performance Analysis of the Classifier in the Classification of Normal-Sleep and Seizure from EEG Signal. Performance Analysis of the Classifier in the Classification of Normal-Sleep and Seizure from EEG Signal.
Sejung Hwang, Soyoung Lee, Eunwoo Kim, Inyoung Hwang, Joo‐Youn Cho, Jae‐Yong Chung, In‐Jin Jang & Jaeseong Oh. (2022) The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects. Clinical and Translational Science 15:9, pages 2116-2126.
Crossref
Crossref
Xian-Chao Chang, Hai Yuan, Yi Wang, Hui-Qin Xu, Wen-Ke Hong & Rong-Yuan Zheng. (2021) Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Crossref
Catalina Gómez, Pablo Arbeláez, Miguel Navarrete, Catalina Alvarado-Rojas, Michel Le Van Quyen & Mario Valderrama. (2020) Automatic seizure detection based on imaged-EEG signals through fully convolutional networks. Scientific Reports 10:1.
Crossref
Crossref
C. Brandt, M. Holtkamp, T. W. May, M. Pfäfflin, M. Mehlig, L. Eggert & E. Kockelmann. (2019) Effektivität von Eslicarbazepinacetat in 2 unterschiedlichen Kohorten von Patienten mit Epilepsie in der klinischen Praxis – Ergebnisse einer retrospektiven Datensammlung aus 2 Epilepsiezentren in DeutschlandEffectiveness of eslicarbazepine acetate in 2 different cohorts of patients with epilepsy in clinical practice—Results from a retrospective data collection from 2 epilepsy centers in Germany. Zeitschrift für Epileptologie 32:2, pages 152-159.
Crossref
Crossref
I. A. Zhydkova, V. A. Karlov & P. N. Vlasov. (2018) New possibilities of pharmacotherapy of epilepsy: eslicarbazepine acetate in treatment of focal epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:4, pages 140.
Crossref
Crossref
Xian-Chao Chang, Hai Yuan, Yi Wang, Hui-Qin Xu, Wen-Ke Hong & Rong-Yuan Zheng. (2017) Eslicarbazepine acetate add-on for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2018:1.
Crossref
Crossref
Philip N. Patsalos, Miguel Zugman, Charlotte Lake, Anthony James, Neville Ratnaraj & Josemir W. Sander. (2017) Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations. Epilepsia 58:7, pages 1234-1243.
Crossref
Crossref
E. Schmid, G. Kuchukhidze, M. Kirschner, M. Leitinger, J. Höfler, A. Rohracher, G. Kalss, A.-S. Wendling, B. J. Steinhoff & E. Trinka. (2017) Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study. Acta Neurologica Scandinavica 135:4, pages 449-453.
Crossref
Crossref
S. D. Shorvon, E. Trinka, B. J. Steinhoff, M. Holtkamp, V. Villanueva, J. Peltola & E. Ben-Menachem. (2017) Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies. Journal of Neurology 264:3, pages 421-431.
Crossref
Crossref
Jukka Peltola, Martin Holtkamp, Rodrigo Rocamora, Philippe Ryvlin, Kasia Sieradzan & Vicente Villanueva. (2015) Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate — Expert opinion. Epilepsy & Behavior 50, pages 46-49.
Crossref
Crossref
Sam A. Booker, Nuno Pires, Stuart Cobb, Patrício Soares-da-Silva & Imre Vida. (2015) Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors. Neuropharmacology 93, pages 103-115.
Crossref
Crossref
J. Helen Cross, Gerhard Kluger & Lieven Lagae. (2013) Advancing the management of childhood epilepsies. European Journal of Paediatric Neurology 17:4, pages 334-347.
Crossref
Crossref
Bernhard J. Steinhoff. (2012) Spezifische Wirkmechanismen gegen epileptische Anfälle. DNP - Der Neurologe und Psychiater 13:9, pages 53-59.
Crossref
Crossref
Anne B Chang, Toby J Lasserson, Justin Gaffney, Frances L Connor & Luke A Garske. (2011) Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jason A. Smith, Peter P. Molesworth, Christopher J.T. Hyland & John H. Ryan. 2011.
491
536
.
Anne B Chang, Brett Taylor, I Brent Masters, Yancy Laifoo & Alexander DH Brown. (2010) Indigenous healthcare worker involvement for Indigenous adults and children with asthma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
C P PanayiotopoulosC P Panayiotopoulos. 2010. A Clinical Guide to Epileptic Syndromes and their Treatment. A Clinical Guide to Epileptic Syndromes and their Treatment
565
620
.